Fertility and Sterility
Volume 84, Issue 2 , Pages 313-318 , August 2005

Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists

Presented in part at the 58th Annual Meeting of the American Society for Reproductive Medicine, Seattle, Washington, October 2002.

  • Karine Chung, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests and present address: Karine Chung, M.D., Penn Fertility Care, 3701 Market Street, Suite 800, Philadelphia, Pennsylvania 19104 (FAX: 215-349-5512).
  • ,
  • Lewis Krey, Ph.D.
  • ,
  • Joseph Katz, Ph.D.
  • ,
  • Nicole Noyes, M.D.

Received 13 September 2004 ,Accepted 15 February 2005.

References 

  1. Noyes N , Krey LC . GnRH antagonists (useful adjuncts for stimulation in women with poor ovarian reserve) . Fertil Steril . 2002;78:S1
  2. Fasouliotis SJ , Laufer N , Sabbagh-Ehrlich S , Lewin A , Hurwitz A , Simon A . Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF . J Assist Reprod Genet . 2003;20:455–460
  3. Grzechocinska B , Fracki S , Marianowski P , Dworniak T , Bablok L , Marianowski L . Protocol of GnRH antagonist in poor responders in IVF-ET cycles . Ginekol Pol . 2003;74:943–948
  4. Akman MA , Erden HF , Tosun SB , Bayazit N , Aksoy E , Bahceci M . Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders (results of a prospective randomized trial) . Hum Reprod . 2001;16:868–870
  5. Nikolettos N , Al-Hasani S , Felberbaum R , Demirel LC , Kupker W , Montzka P , et al.   Gonadotropin-releasing hormone antagonist protocol (a novel method of ovarian stimulation in poor responders) . Eur J Obstet Gynecol Reprod Biol . 2001;97:202–207
  6. Albano C , Felberbaum RE , Smitz J , Riethmuller-Winzen H , Engel J , Diedrich K , et al.  European Cetrorelix Study Group   Ovarian stimulation with hMG (results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin) . Hum Reprod . 2000;15:526–531
  7. Hillier SG . Gonadotropic control of ovarian follicular growth and development . Mol Cell Endocrinol . 2001;179:39–46
  8. Fleming R , Lloyd F , Herbert M , Fenwick J , Griffiths T , Murdoch A . Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone . Hum Reprod . 1998;13:1788–1792
  9. Balasch J , Vidal E , Penarrubia J , Casamitjana R , Carmona F , Creus M , et al.   Suppression of LH during ovarian stimulation (analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH) . Hum Reprod . 2001;16:1636–1643
  10. The Ganirelix Dose-Finding Study Group . A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon) . Hum Reprod . 1998;13:3023–3031
  11. Filcori M , Cognigni GE . Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction . J Clin Endocrinol Metab . 2001;86:1437–1441
  12. Sullivan MW , Stewart-Akers A , Krasnow JS , Berga SL , Zeleznik AJ . Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH) (a role for LH in the final stages of follicular maturation) . J Clin Endocrinol Metab . 1999;84:228–232
  13. Esposito MA , Barnhart KT , Coutifaris C , Patrizio P . Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone . Fertil Steril . 2001;75:519–524
  14. Westergaard LG , Laursen SB , Andersen CY . Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction . Hum Reprod . 2000;15:1003–1008
  15. Penarrubia J , Fabregues F , Creus M , Manau D , Casamitjana R , Guimera M , et al.   LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH . Hum Reprod . 2003;18:2689–2697
  16. Bendiva CA , Ben-Rafael Z , Strauss JF , Mastroianni L , Flickinger GL . Ovarian response of individuals to different doses of human menopausal gonadotropin . Fertil Steril . 1998;49:997–1001
  17. Daya S , Gunby J , Hughes EG , Collins JA , Sagle MA . Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles (a meta-analysis) . Fertil Steril . 1995;64:347–354
  18. Agrawal R , Holmes J , Jacobs HS . Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles (a meta-analysis) . Fertil Steril . 2000;73:338–343
  19. van Wely M , Westergaard LG , Bossuyt PM , van der Veen F . Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles (a meta-analysis) . Fertil Steril . 2003;80:1086–1093
  20. Albano C , Smitz J , Camus M , Riethmuller-Winzen H , Siebert-Weigel M , Diedrich K , et al.   Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix) . Hum Reprod . 1996;11:2114–2118
  21. Diedrich K , Diedrich C , Santos E , Zoll C , al-Hasani S , Reissmann T , et al.   Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation . Hum Reprod . 1994;9:788–791
  22. Cedrin-Durnerin I , Grange-Dujardin D , Laffy A , Parneix I , Massin N , Galey J , et al.   Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles (a prospective randomized study) . Hum Reprod . 2004;19:1979–1984
  23. Loutradis D , Elsheikh A , Kallianidis K , Drakakis P , Stefanidis K , Milingos S , et al.   Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations . Arch Gynecol Obstet . 2004;270:223–226
  24. Laml T , Obruca A , Fischl F , Huber JC . Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women . Gynecol Endocrinol . 1999;13:98–103
  25. Ferrari B , Barusi L , Coppola F . Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study . J Reprod Med . 2002;47:137–143
  26. Creus M , Penarrubia J , Fabregues F , Vidal E , Carmona F , Casamitjana R , et al.   Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome . Hum Reprod . 2000;15:2341–2346
  27. Westergaard LG , Erb K , Steen B , Rex S , Rasmussen PE . Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotrophic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmatic sperm injection (a prospective randomized study) . Fertil Steril . 2001;76:543–549
  28. Serhal P , Phopong P , Ranieri DM . Comparison between human menopausal gonadotropin and recombinant FSH for ovarian stimulation in patients undergoing in-vitro fertilization . Hum Reprod . 2000;15:143
  29. Commenges-Ducos M , Piault S , Papaxanthos A , Ribes C , Dallay I , Commenges D . Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization . Fertil Steril . 2002;78:1049–1054

PII: S0015-0282(05)00917-9

doi: 10.1016/j.fertnstert.2005.02.028

Fertility and Sterility
Volume 84, Issue 2 , Pages 313-318 , August 2005